Quarterly report pursuant to Section 13 or 15(d)

Stockholders' equity (Tables)

v3.23.3
Stockholders' equity (Tables)
3 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of warrants or rights
The activity related to warrants for the three months ended September 30, 2023, is summarized, after giving effect to the Reverse Stock Split, as follows:
 
     Common
Stock from
Warrants
     Weighted-
average
Exercise
Price
(per
share)
 
Outstanding at July 1, 2023
     2,348,039      $ 1.92  
Pre-funded warrants issued August 11, 2023
     15,126,226      $ 0.0001  
Common warrants issued August 11, 2023
     16,002,175      $ 3.86  
Outstanding at September 30, 2023
     33,476,440      $ 1.98  
Exercisable at September 30, 2023
     33,476,440      $ 1.98  
Schedule of equity awards
The activity related to equity awards, which are comprised of stock options during the three months ended September 30, 2023 is summarized as follows:
 

 
  
Stock
Options
 
  
Weighted-
average
Exercise
Price
 
  
Weighted-
average
Remaining
Contractual
Term
 
  
Aggregate
Intrinsic
Value
 
Outstanding at June 30, 2023
     107,993      $ 31.88        8.96 years      $ 11,888  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding at September 30, 2023
     107,993      $ 31.88        8.70 years      $ 342  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Exercisable at September 30, 2023
     27,135      $ 88.79        6.97 years      $ —   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schedule of equity-based compensation expense
The classification of share-based compensation expense is summarized as follows:
 
     Three Months Ended
September 30,
 
(US$’000)    2023      2022  
Research and development
   $ 34      $ 30  
General and administrative
     57        272  
    
 
 
    
 
 
 
Total share-based compensation expense
   $ 91      $ 302